π Alcohol & Drug Abuse (ALC)
Federal lobbying activity for the alcohol & drug abuse issue area
AI Overview
Alcohol & Drug Abuse (ALC) has attracted $30.4M in lobbying spending across 2,282 filings. This issue area sees targeted lobbying from organizations with specific policy interests.
Spending by Year
Top Clients
Top Lobbying Firms
| # | Firm | Revenue |
|---|---|---|
| 1 | Acg Advocacy | $2.5M |
| 2 | S-3 Group | $1.8M |
| 3 | Cornerstone Government Affairs, INC. | $1.7M |
| 4 | Winning Strategies Washington | $1.6M |
| 5 | Powers Pyles Sutter & Verville, P.C. | $1.6M |
| 6 | Harbinger Strategies, LLC | $1.3M |
| 7 | Alpine Group Partners, LLC. | $1.2M |
| 8 | Capitol Decisions, INC. | $1.1M |
| 9 | Knight Capitol Consultants | $990K |
| 10 | Townsend Public Affairs, INC | $944K |
| 11 | Williams and Jensen, PLLC | $910K |
| 12 | Splitoak Strategies LLC | $900K |
| 13 | Clark Hill, PLC | $830K |
| 14 | Cgcn Group, LLC | $763K |
| 15 | Federal Street Strategies, LLC | $740K |
| 16 | Van Scoyoc Associates | $685K |
| 17 | Arnold & Porter Kaye Scholer LLP | $540K |
| 18 | Ballard Partners | $530K |
| 19 | Tiber Creek Group | $510K |
| 20 | Keller Partners & Company | $500K |
Sample Lobbying Descriptions
β’Controlled Substance act improvements. Opioid overdose death reduction. Alprazolam rescheduling.
β’Educating congressional and administration officials on data analytics and federal programs.
β’Public Law 114-198, Comprehensive Addiction and Recovery Act (CARA); and policies to address the treatment of opioid/alcohol/drug addiction and mental-health related issues.
β’Working to close loop holes that would permit tobacco products from being accessible to and used by kids. Specifically working on related riders in federal appropriation bills.
β’Appropriations and authorization for programs related to children and families affected by grief and addiction.
β’Working to make it easier to get Medicare/Medicaid coverage for a medical device that eases patients off of opioids and into treatment.
β’National Drug Abuse Crisis and related bills. 42 CFR Part 2 - advocating to align 42 CFR Part 2 (substance use privacy regulations) with HIPAA to allow appropriate access to patient information that
β’Tracking pharmaceuticals throughout the supply chain
β’Anti-Doping efforts. FY 2018 Funding.
β’Anti-Doping Issues. H.R.2651: Horseracing Integrity Act of 2017.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.